Tetanus (Clostridium tetani Infection)

Tetanus is a highly fatal, toxemic infectious disease of cattle caused by the neurotoxin produced by Clostridium tetani, a Gram-positive, strictly anaerobic, spore-forming bacillus. The disease is characterized by progressive muscular rigidity, spastic paralysis, and hyperesthesia, resulting from the action of tetanospasmin on the central nervous system. In cattle, tetanus typically occurs following contamination of wounds, surgical procedures (e.g., castration, dehorning, ear tagging), or parturition with soil or feces containing spores. The disease is sporadic but carries a high case fatality rate (often 50-80% or higher) if untreated. Economically, tetanus causes significant losses due to mortality, treatment costs, and reduced productivity in affected herds. The disease is not contagious between animals but is a major concern in management-intensive systems where invasive procedures are performed without adequate hygiene or prophylaxis.

The causative agent is Clostridium tetani, a ubiquitous, Gram-positive, strictly anaerobic, motile rod that forms terminal, spherical spores (drumstick appearance). The organism exists in soil, dust, and the gastrointestinal tract of animals and humans. Tetanus occurs when spores are introduced into devitalized tissue or wounds with low oxygen tension. Germination of spores requires necrotic tissue, foreign bodies, or concurrent bacterial infection that reduces local oxidation-reduction potential. The vegetative cells produce two exotoxins: tetanospasmin (the primary neurotoxin) and tetanolysin (a hemolysin that damages tissue and enhances conditions for toxin production). Tetanospasmin is a zinc-dependent metalloprotease that binds to gangliosides at the neuromuscular junction, is internalized, and transported retrograde along motor axons to the central nervous system. It then blocks the release of inhibitory neurotransmitters (GABA and glycine) from Renshaw cells in the spinal cord and brainstem, leading to unopposed motor neuron activity and spastic paralysis. The toxin is extremely potent; as little as 1 ng/kg is lethal in some species. In cattle, common portals of entry include castration wounds, dehorning sites, ear tags, umbilical infections in calves, uterine contamination after dystocia, and puncture wounds from foreign bodies. The incubation period ranges from 1 to 3 weeks, depending on the distance of the wound from the CNS and the toxin dose.

Tetanus occurs worldwide, with higher incidence in agricultural regions where soil is rich in organic matter and where livestock management involves invasive procedures. In cattle, the disease is sporadic, affecting individual animals rather than causing herd outbreaks, but multiple cases can occur in a herd following a common management practice (e.g., a batch of calves castrated with contaminated equipment). All ages and breeds are susceptible, but young calves and yearlings are at higher risk due to routine procedures such as castration, dehorning, and ear tagging. Beef cattle on pasture may be at increased risk due to exposure to soil-contaminated wounds, while dairy cattle may develop tetanus after calving injuries or surgical interventions. The case fatality rate is high, often exceeding 50% even with treatment, and can reach 80-100% in severe cases. Morbidity within a herd is typically low (<1%), but the economic impact per case is substantial due to treatment costs and death loss. Seasonal patterns may reflect calving seasons and management practices. Poor hygiene, lack of tetanus toxoid vaccination, and inadequate wound care are major risk factors.

The pathophysiology of tetanus is primarily neurotoxic. After spores germinate in contaminated wounds, vegetative cells produce tetanospasmin. The toxin binds to presynaptic motor neuron terminals at the neuromuscular junction, then undergoes retrograde axonal transport to the spinal cord and brainstem. Within the CNS, the toxin cleaves synaptobrevin, a vesicle-associated membrane protein, preventing the release of inhibitory neurotransmitters (GABA and glycine) from Renshaw cells and other inhibitory interneurons. This results in unopposed excitatory output to motor neurons, causing sustained muscle contraction (spastic paralysis). The toxin also affects the autonomic nervous system, leading to sympathetic overactivity, which can cause tachycardia, hypertension, and sweating. In cattle, clinical signs include stiff gait, erect ears, prolapsed third eyelid, trismus (lockjaw), dysphagia, bloat due to rumen stasis, and respiratory distress. The severity depends on the toxin dose and the proximity of the wound to the CNS. The disease is not associated with systemic inflammation or fever unless secondary infections occur. Death usually results from respiratory failure or aspiration pneumonia.

Intrinsic factors include age (young animals undergoing procedures), sex (males castrated), and individual immune status (unvaccinated animals). Extrinsic factors are more significant: poor hygiene during surgical procedures, use of non-sterile equipment, contamination of wounds with soil or feces, inadequate wound debridement, and lack of tetanus toxoid vaccination. Management practices such as castration, dehorning, ear tagging, and tail docking without proper aseptic technique and postoperative care increase risk. Calving in dirty environments can lead to uterine contamination and subsequent tetanus. Feedlot cattle may be at risk due to penetrating wounds from foreign objects. Additionally, any condition that creates devitalized tissue (e.g., trauma, abscesses, necrotic umbilical remnants) predisposes to spore germination.

Clinical signs in cattle typically appear 1-3 weeks after the initial wound. Early signs include stiffness and slight gait abnormalities, often first noticed as a reluctance to move. As the disease progresses, generalized muscular rigidity becomes evident: the animal stands with a sawhorse stance, the tail is slightly elevated, and the ears are erect. The third eyelid (nictitating membrane) prolapses, especially when the head is elevated or the animal is stimulated. Trismus (lockjaw) develops, leading to difficulty in prehension and mastication, drooling, and dysphagia. Bloat occurs due to rumen stasis and inability to eructate. Hyperesthesia is pronounced; sudden noises or touch can trigger violent extensor spasms. Body temperature may be normal or slightly elevated, but fever is not a consistent feature. In severe cases, respiratory distress, cyanosis, and recumbency occur, leading to death. The disease is often fatal if untreated, with a course of 3-10 days.

Differential diagnoses include: (1) Hypocalcemia (milk fever) – typically occurs in early lactation, with flaccid paralysis rather than spasticity, and responds to calcium therapy. (2) Hypomagnesemia (grass tetany) – associated with low magnesium, causes hyperesthesia and convulsions but not trismus or third eyelid prolapse. (3) Polioencephalomalacia (PEM) – caused by thiamine deficiency, presents with cortical blindness, head pressing, and opisthotonos, but not generalized rigidity. (4) Rabies – causes progressive paralysis, behavioral changes, and is invariably fatal; history of exposure and Negri bodies on histopathology. (5) Strychnine poisoning – causes severe muscle spasms but is rare in cattle; history of exposure. (6) Meningitis – fever, depression, and neck stiffness, but not the classic third eyelid prolapse. (7) Lead poisoning – neurological signs including blindness and circling, but not trismus. (8) Tetanus-like syndrome due to other clostridial toxins (e.g., Clostridium botulinum) – botulism causes flaccid paralysis, not spasticity.

Diagnosis is primarily based on characteristic clinical signs and history of a wound or recent invasive procedure. A step-by-step approach: (1) Obtain a thorough history, including recent castration, dehorning, calving, or trauma. (2) Perform a complete physical examination, looking for the classic triad of trismus, third eyelid prolapse, and generalized rigidity. (3) Assess response to stimuli (hyperesthesia). (4) Rule out other causes of neurological disease via differential diagnosis. (5) Laboratory tests are generally not helpful; blood work may show elevated creatine kinase due to muscle damage, but this is nonspecific. (6) If the wound is identified, anaerobic culture and toxin detection (mouse bioassay) can confirm, but this is rarely performed due to time and cost. (7) Necropsy findings are nonspecific; diagnosis is based on clinical signs and history.

There are no pathognomonic laboratory findings. Complete blood count may be normal or show mild leukocytosis due to stress or secondary infection. Serum biochemistry may reveal elevated creatine kinase (CK) and aspartate aminotransferase (AST) due to muscle rigidity and recumbency. Electrolytes are usually within normal limits. Cerebrospinal fluid analysis is normal, which helps rule out meningitis. In cases where the wound is cultured, Clostridium tetani may be isolated, but this is not routinely performed. Toxin detection in serum or tissue via mouse bioassay is possible but impractical in clinical settings. Therefore, diagnosis relies on clinical presentation and history.

Imaging is not typically used for diagnosis of tetanus. However, radiography or ultrasonography may be employed to identify a foreign body or deep wound that could serve as the portal of entry. In cases of suspected aspiration pneumonia secondary to dysphagia, thoracic radiography or ultrasonography may reveal consolidation. Otherwise, imaging is of limited value.

Cytology and histopathology are not commonly performed for antemortem diagnosis. At necropsy, gross lesions are often absent. Histopathological examination of the central nervous system may show no specific changes, although some cases may exhibit mild chromatolysis of motor neurons. The diagnosis is confirmed by clinical signs and history. In research settings, immunofluorescence or PCR can detect the toxin or organism in tissues, but these are not routine.

Treatment of tetanus in cattle is challenging and requires intensive nursing care. The goals are to neutralize unbound toxin, eliminate the source of toxin, control muscle spasms, and provide supportive care. Specific measures include: (1) Administer tetanus antitoxin (equine origin) at a dose of 100,000-200,000 IU IV or SC, to neutralize circulating toxin. This is most effective if given early. (2) Identify and debride the wound, removing necrotic tissue and foreign material, and irrigate with hydrogen peroxide or saline. (3) Administer antibiotics to eliminate vegetative C. tetani: Penicillin G procaine at 20,000-40,000 IU/kg IM or SC q12h, or oxytetracycline at 10-20 mg/kg IV or IM q24h, for 7-10 days. (4) Control muscle spasms with tranquilizers or muscle relaxants: Acepromazine (0.05-0.1 mg/kg IM q6-8h) or xylazine (0.05-0.1 mg/kg IV or IM) as needed, but caution with xylazine due to potential respiratory depression. Diazepam (0.1-0.2 mg/kg IV) can be used for severe spasms. (5) Provide supportive care: Place the animal in a quiet, dark, well-bedded stall to minimize stimulation. If recumbent, turn frequently to prevent decubital sores. Provide fluid therapy (balanced electrolyte solutions) and nutritional support via stomach tube if dysphagia prevents eating. (6) Manage bloat by passing a stomach tube or performing rumenocentesis if necessary. (7) Administer anti-inflammatory drugs such as flunixin meglumine (1.1-2.2 mg/kg IV q24h) to reduce pain and inflammation. (8) In severe cases, consider tracheostomy if respiratory distress is severe. Prognosis is guarded, and recovery may take weeks.

The prognosis for tetanus in cattle is poor to guarded, with a case fatality rate of 50-80% even with treatment. Factors that worsen prognosis include: short incubation period (indicating high toxin load), rapid progression of clinical signs, recumbency, and respiratory compromise. Animals that remain standing and are treated early have a better chance of recovery. Recovery is slow, often taking 2-4 weeks, and survivors may have residual stiffness or muscle damage. Economic losses include death loss, treatment costs, and reduced productivity. Prevention through vaccination and proper wound care is far more effective than treatment.

Follow-up care for surviving animals includes continued nursing, gradual reintroduction of feed, and monitoring for complications such as aspiration pneumonia, bloat, and decubital ulcers. The animal should be kept in a low-stress environment until full recovery. For the herd, review management practices to prevent future cases: ensure proper hygiene during castration, dehorning, and other procedures; use clean, disinfected equipment; consider tetanus toxoid vaccination for at-risk animals (e.g., calves before castration). If multiple cases occur, evaluate vaccination protocols and consider administering tetanus antitoxin to animals at high risk.

Pearls: (1) The classic triad of trismus, third eyelid prolapse, and generalized rigidity is highly suggestive of tetanus. (2) Early administration of antitoxin is crucial; once toxin is fixed in the CNS, antitoxin is ineffective. (3) Penicillin is the antibiotic of choice to eliminate vegetative bacteria. (4) Minimize stimulation to reduce spasms. Pitfalls: (1) Mistaking tetanus for hypocalcemia or other neurological diseases can delay treatment. (2) Using xylazine excessively can cause respiratory depression. (3) Failing to debride the wound thoroughly may allow continued toxin production. (4) Neglecting supportive care (e.g., turning recumbent animals) can lead to secondary complications. (5) Assuming that vaccination is unnecessary in low-risk herds; tetanus toxoid is inexpensive and effective.

Based on Plumb's Veterinary Drug Handbook and AABP guidelines, the following protocols are recommended: (1) Tetanus antitoxin: 100,000-200,000 IU IV or SC, once. (2) Penicillin G procaine: 20,000-40,000 IU/kg IM or SC q12h for 7-10 days. (3) Oxytetracycline: 10-20 mg/kg IV or IM q24h for 7-10 days (alternative). (4) Acepromazine: 0.05-0.1 mg/kg IM q6-8h as needed for sedation. (5) Diazepam: 0.1-0.2 mg/kg IV for acute spasms. (6) Flunixin meglumine: 1.1-2.2 mg/kg IV q24h for 1-3 days. (7) Fluid therapy: Balanced electrolyte solution (e.g., lactated Ringer's) at 40-60 mL/kg/day IV, adjusted based on hydration status. (8) For bloat: Stomach tube or rumenocentesis. Withdrawal times: Penicillin G procaine has a milk withdrawal of 48 hours and meat withdrawal of 4 days; oxytetracycline has a milk withdrawal of 96 hours and meat withdrawal of 28 days; flunixin meglumine has a milk withdrawal of 36 hours and meat withdrawal of 4 days. Always consult label and veterinary supervision.

Tetanus in cattle is well-described in standard veterinary textbooks, but there are few recent clinical trials due to the sporadic nature of the disease. Rebhun's Diseases of Dairy Cattle (Divers & Peek) provides comprehensive guidance on diagnosis and treatment, emphasizing the importance of early antitoxin administration and wound debridement. Veterinary Medicine (Constable et al.) discusses the pathophysiology and clinical approach. Anecdotal reports and case series suggest that aggressive treatment with antitoxin, antibiotics, and muscle relaxants can improve survival, but mortality remains high. Vaccination with tetanus toxoid is highly effective and is recommended in high-risk situations. The AABP guidelines on calf management recommend tetanus prophylaxis for castration and dehorning. Overall, evidence is limited, but the principles of treatment are well-established.